Your browser doesn't support javascript.
loading
HIV-1 Vif suppresses antiviral immunity by targeting STING.
Wang, Yu; Qian, Gui; Zhu, Lingyan; Zhao, Zhuo; Liu, Yinan; Han, Wendong; Zhang, Xiaokai; Zhang, Yihua; Xiong, Tingrong; Zeng, Hao; Yu, Xianghui; Yu, Xiaofang; Zhang, Xiaoyan; Xu, Jianqing; Zou, Quanming; Yan, Dapeng.
Afiliação
  • Wang Y; Department of Immunology, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity & Shanghai Public Health Clinical Center, Fudan University, Shanghai, 200032, China.
  • Qian G; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
  • Zhu L; Department of Basic Courses, NCO School, Army Medical University, Shijiazhuang, 050081, China.
  • Zhao Z; Department of Immunology, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity & Shanghai Public Health Clinical Center, Fudan University, Shanghai, 200032, China.
  • Liu Y; Department of Immunology, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity & Shanghai Public Health Clinical Center, Fudan University, Shanghai, 200032, China.
  • Han W; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
  • Zhang X; Department of Immunology, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity & Shanghai Public Health Clinical Center, Fudan University, Shanghai, 200032, China.
  • Zhang Y; Biosafety Level 3 Laboratory, Fudan University, Shanghai, 200032, China.
  • Xiong T; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
  • Zeng H; Department of Immunology, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity & Shanghai Public Health Clinical Center, Fudan University, Shanghai, 200032, China.
  • Yu X; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
  • Yu X; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, 400038, China.
  • Zhang X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.
  • Xu J; Institute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, 130061, China.
  • Zou Q; Department of Immunology, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity & Shanghai Public Health Clinical Center, Fudan University, Shanghai, 200032, China.
  • Yan D; Shanghai Key Laboratory of Organ Transplantation, Zhongshan Hospital & Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. xujianqing@shphc.org.cn.
Cell Mol Immunol ; 19(1): 108-121, 2022 01.
Article em En | MEDLINE | ID: mdl-34811497
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: HIV-1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: HIV-1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China